Business Wire

Final results from landmark DYNAGITO® trial published in The Lancet Respiratory Medicine1

Jaa

Boehringer Ingelheim today announced data from the landmark 52-week DYNAGITO® trial which show that in people with COPD (chronic obstructive pulmonary disease), Spiolto® Respimat® (tiotropium/olodaterol 5/5µg) lowers the rate of moderate-to-severe exacerbations compared with Spiriva® Respimat® (tiotropium). The pre-specified significance level of p<0.01 for the primary endpoint of DYNAGITO® was not met.1 Treatment with tiotropium/olodaterol resulted in a 7% lower rate of moderate-to-severe COPD exacerbations compared with tiotropium alone (p=0.0498).1 This study, involving more than 7,800 people with COPD over 1 year, was published today in The Lancet Respiratory Medicine.1

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180329005455/en/

Importance of Preventing COPD Exacerbations (Infographic: Business Wire)

Importance of Preventing COPD Exacerbations (Infographic: Business Wire)

“The results of DYNAGITO® are of value, as they show that tiotropium/olodaterol can lower the rate of moderate-to-severe exacerbations in many patients compared to tiotropium – a tough comparator which has consistently demonstrated exacerbation risk reduction through long-term, real-world experience,” said study investigator Professor Peter M.A. Calverley, Professor of Pulmonary Medicine, University of Liverpool, UK. “These data support evidence-based expert recommendations that dual bronchodilator LAMA/LABA therapy has a central role in the management of people with COPD, in terms of symptom improvement and exacerbation risk reduction.”7

COPD is a progressive, yet treatable condition that significantly impacts patients’ lives, restricting their daily activities from early on in the disease.8,9,10 COPD exacerbations, or flare-ups, are sudden episodes of increased breathlessness, cough and mucus production that can last for several days or even weeks.11 These episodes can be seriously disabling, resulting in a need for urgent medical care, including hospitalisation, and sometimes lead to death.11

Further DYNAGITO® data demonstrated that tiotropium/olodaterol was associated with fewer moderate-to-severe exacerbations that needed intervention with a systemic corticosteroid, with or without antibiotics, compared with tiotropium:1*

  • A 20% lower rate of moderate-to-severe exacerbations that required treatment with a systemic corticosteroid (p=0.0068).1*
  • A 9% lower rate of exacerbations where the use of both a systemic corticosteroid and antibiotics were needed (p=0.0447).1*
  • No difference was observed in the rate of exacerbations that required treatment with antibiotics only (p=0.2062).1*

No new side effects or safety concerns were identified in the DYNAGITO® study.1 These data also show that tiotropium/olodaterol has a similar safety profile to tiotropium.1

Reducing symptoms and the future risk of exacerbations are key treatment goals for COPD.7 According to the international GOLD 2018 Strategy recommendations, LAMA/LABA treatments such as tiotropium/olodaterol play a central role in the management of COPD and help to achieve these treatment goals.7

Intended audiences:
This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.

For references and notes to editors, please visit: http://www.boehringer-ingelheim.com/press-release/results-landmark-dynagito-trial

* The pre-specified significance level of p<0.01 for the primary endpoint of DYNAGITO® was not met
Global Initiative for Chronic Obstructive Lung Disease

Contact information

Boehringer Ingelheim
Corporate Communications
Media + PR
Dr. Carolin Grob
Email: carolin.grob@boehringer-ingelheim.com
Phone: +49 (6132) 77-182603
Fax: +49 (6132) 77-6601
or
Email: press@boehringer-ingelheim.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

SIFLEX Switches to Rimini Street Support for Its SAP Application24.4.2018 02:00Tiedote

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced that SIFLEX, a leading global printed circuit board (PCB) manufacturer headquartered in South Korea, has switched its SAP ERP support to Rimini Street from the vendor. By making the switch, SIFLEX was able to reduce its maintenance fees by 50% and can now maximize its current, stable and robust ERP ECC 5.0 system for a minimum of 15 years from the time the company transitioned to Rimini Street support. SIFLEX was also able to free up internal IT personnel to focus on more pressing initiatives within the organization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180423006227/en/ Leading Korean manufacturer of printed circuit boards, SIFLEX, Switches to Rimini Street Support for its SAP Application (Photo: Business Wire) Seeking

REPLY S.p.A.: Shareholders’ Meeting Approves the 2017 Financial Statements23.4.2018 18:10Tiedote

Consolidated turnover of €884.4 million (+13.3%); Group net profits of €77.9 million (+ 15.3%). The proposal to distribute a dividend of €0.35 per share has been approved. The Board of Directors and the Board of Statutory Auditors have been appointed for the three-year period 2018-2020. Resolutions in relation to the purchase and/or sale of own shares. Reply S.p.A. Shareholders’ meeting [MTA, STAR: REY] today approved the Financial Statements for the financial year 2017, confirming the distribution of a gross dividend of €0.35 per share (up 21.7% compared to the previous year, taking into consideration the equity split occurred in October 2017, which converted each ordinary share, having a nominal value of €0.52 into 4 new ordinary shares, nominal value of €0.13). The dividend will be paid on 9 May 2018, with dividend detachment date set on 7 May 2018 and record date 8 May 2018. Financial Statements of the 2017 financial year The Reply Group closed the 2017 financial year with a consol

ABB and the Economist Launch Automation Readiness Index, Global Ranking for Robotics and Artificial Intelligence23.4.2018 17:35Tiedote

South Korea, Germany and Singapore are the world’s top-ranked nations in their preparations for smoothly integrating intelligent automation into their economies, according to an index and report released today by ABB and The Economist Intelligence Unit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180423005873/en/ The report "The Automation Readiness Index (ARI): Who Is Ready for the Coming Wave of Innovation?" finds that even the best-prepared countries must develop even more effective education policies and training programs, as well as place a new emphasis on continual learning over the course of a career. Those policies and programs, the report recommends, must ensure that the rapid adoption of automation technologies and artificial intelligence (AI) will not leave people unprepared for the new, more human-oriented jobs that will be needed as robots and algorithms take on more of the routine tasks that can be and will

Finablr Launched To Accelerate Customer-Focused Technology Innovations23.4.2018 15:55Tiedote

Noted UAE-based businessman and philanthropist, Dr. Bavaguthu Raghuram Shetty announced the creation of “Finablr”, a new holding company which, subject to regulatory approvals, will consolidate his global portfolio of financial services brands under one single umbrella. Incorporated in the UK, Finablr will provide strategic direction and oversight for the category-leading brands across its network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180423005741/en/ Finablr Leadership Team (L-R): Binay Shetty (Executive Director, Finablr), Dr. B.R. Shetty (Founder and Chairman, Finablr) and Promoth Manghat (Executive Director, Finablr) (Photo: AETOSWire) Finablr also seeks to drive financial enablement and empowerment by accelerating customer-focused technology innovation through R&D efforts, industry ecosystem engagements, investments and potential acquisitions. As a diversified network, Finablr will combine the cumulative indus

Abu Dhabi Fund for Development Finances US$192 Million Sheikh Khalifa bin Zayed City in Afghanistan23.4.2018 15:37Tiedote

His Excellency Mohammad Ashraf Ghani, President of Afghanistan, inaugurated the Abu Dhabi Fund for Development (ADFD) financed Sheikh Khalifa bin Zayed City Housing Complex in Afghanistan. Located in the Qasaba district of Afghanistan’s capital Kabul, ADFD contributed an estimated US$192 million to the social housing development project. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180423005711/en/ His Excellency Mohammed Saif Al Suwaidi, Director General of ADFD, during the official inauguration ceremony of the 3,330-residential unit Sheikh Khalifa bin Zayed City in Afghanistan (Photo: AETOSWire) Aimed at increasing the supply of affordable accommodation options in the country, the crucial project encompasses 3,330 residential units. Including extensive infrastructure works such as roads, water, and electricity networks and support services, the project seeks to elevate living standards for its residents through its power

Rockwell Automation Simplifies Analytics for Industrial Productivity23.4.2018 15:00Tiedote

Industrial organizations must be able to quickly identify ways to tighten production schedules and maximize revenue. Gaining insight into operations and production capabilities to make informed decisions has often involved time-intensive IT projects and a highly specialized skillset. Today, Rockwell Automation expands the FactoryTalk® Analytics portfolio, a robust advanced analytics environment that empowers users with the ability to quickly and confidently make informed decisions. These latest advancements were developed to reduce the complexity of the operations environment for manufacturers and producers and their employees who are driving operations. FactoryTalk Analytics has been developed for scale, discovering and connecting data sources from the edge of the network up through the enterprise, and then intelligently fusing the information to resolve issues close to the source. At the edge or the device, this can result in near-immediate resolution of production issues. Empowered

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme